Search

everythinglearnresearchcommunity

for

Search:↓

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

A man's adrenal insufficiency was caused by a pituitary tumor linked to kidney cancer.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

A rare skin tumor with bone formation was successfully removed without recurrence.

Increasing SSAT makes skin more prone to cancer.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

The drug combination was safe and showed promise in treating advanced tumors.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Selenium shows promise in preventing and controlling prostate cancer.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.